In AML, CML and CLL patient samples at 6h following treatment we saw an up-regulation of sirt1 and c-myc expression compared to non-treated samples (Figure 6D). This evidence concerns the gene SIRT1 and chronic myelogenous leukemia, BCR-ABL1 positive.